发明名称 |
THERAPEUTIC USE OF FACTOR XI |
摘要 |
<p>The present invention provides methods and compositions for treating bleeding episodes. The methods are carried out by administering to a patient in need thereof a preparation comprising a factor XI polypeptide, in an amount effective for such treatment. The methods of the invention result in one or more of: reduced clotting time; enhancement of hemostasis; increase in clot lysis time; increase in clot strength; and/or increase in overall clot quality (OCQ) in said patient.</p> |
申请公布号 |
CA2540986(A1) |
申请公布日期 |
2005.06.02 |
申请号 |
CA20042540986 |
申请日期 |
2004.11.22 |
申请人 |
NOVO NORDISK HEALTH CARE AG |
发明人 |
JENSEN, SIMON BJERREGAARD;VIUFF, DORTHE;OESTERGAARD, SOEREN;HANSEN, JENS JACOB;ROEJKJAER, RASMUS |
分类号 |
A61K38/36;A61K38/10;A61K38/48;A61K38/55;A61P7/00;A61P7/04 |
主分类号 |
A61K38/36 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|